The Patent Ductus Arteriosus Problem: Infants Who Still Need Treatment.

about

Ibuprofen and indomethacin differentially regulate vascular endothelial growth factor and its receptors in ductus arteriosus endothelial cells.

P2860

Q47337871-9C16423D-11B8-4241-8556-AB756A7D9E27

P2860

The Patent Ductus Arteriosus Problem: Infants Who Still Need Treatment.

Item

http://www.wikidata.org/entity/Q47134264

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh-hant

name

The Patent Ductus Arteriosus Problem: Infants Who Still Need Treatment.

@en

The Patent Ductus Arteriosus Problem: Infants Who Still Need Treatment.

@nl

type

Item

label

The Patent Ductus Arteriosus Problem: Infants Who Still Need Treatment.

@en

The Patent Ductus Arteriosus Problem: Infants Who Still Need Treatment.

@nl

prefLabel

The Patent Ductus Arteriosus Problem: Infants Who Still Need Treatment.

@en

The Patent Ductus Arteriosus Problem: Infants Who Still Need Treatment.

@nl

P1476

The Patent Ductus Arteriosus Problem: Infants Who Still Need Treatment.

@en

P2093

Matthew M Laughon

http://www.w3.org/2001/XMLSchema#string

P2860

Patent ductus arteriosus ligation and adverse outcomes: causality or bias?

Early surgical ligation versus a conservative approach for management of patent ductus arteriosus that fails to close after indomethacin treatment

The treatment of patent ductus arteriosus in preterm infants. A review and overview of randomized trials.

Patency of the ductus arteriosus in the premature infant: is it pathologic? Should it be treated?

Neurodevelopmental outcomes following two different treatment approaches (early ligation and selective ligation) for patent ductus arteriosus

Treatment strategies to prevent or close a patent ductus arteriosus in preterm infants and outcomes.

Patent ductus arteriosus: lack of evidence for common treatments.

Conservative treatment for patent ductus arteriosus in the preterm.

Patent ductus arteriosus therapy: impact on neonatal and 18-month outcome.

Treatment of persistent patent ductus arteriosus in preterm infants: time to accept the null hypothesis?

P304

954-956

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.1016/J.JPEDS.2015.08.023

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

167

http://www.w3.org/2001/XMLSchema#string

P50

John Jeffrey Reese

P577

2015-08-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26316368

http://www.w3.org/2001/XMLSchema#string

P932

5666689

http://www.w3.org/2001/XMLSchema#string

The Patent Ductus Arteriosus Problem: Infants Who Still Need Treatment.

about

P2860

P2860

The Patent Ductus Arteriosus Problem: Infants Who Still Need Treatment.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932